All In Biotech

Free tool

FAERS Monitor: Diclegis

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021876 or its brand name (Diclegis, Doxylamine Succinate, Pyridoxine Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

409

Serious

211

52% of reports

Hospitalization

86

Death reported

11

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • maternal exposure during pregnancy50
  • premature delivery43
  • exposure during pregnancy40
  • foetal exposure during pregnancy36
  • nausea33
  • somnolence32
  • vomiting31
  • drug ineffective24
  • off label use22
  • abortion spontaneous21
  • headache20
  • dizziness13
  • migraine13
  • pre-eclampsia13
  • anxiety12

Reports by year received

View as table
YearReports
20133
20146
201531
201667
201777
201876
201941
202026
202115
202211
202316
202411
202519
202610

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,750 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
pre-eclampsiaSignal13141.182.61,666
premature deliverySignal43139.2104.95,753
exposure during pregnancySignal4033.124.71,217
maternal exposure during pregnancySignal5028.922.31,322
abortion spontaneousSignal2127.017.8500
foetal exposure during pregnancySignal3622.816.7731
somnolenceSignal328.25.9196
migraineSignal137.04.161
vomitingSignal313.42.451
anxietySignal122.21.27
nauseaSignal332.11.520
headache201.61.15
dizziness131.30.81
off label use221.30.91
drug ineffective240.90.60

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.